Pharmaceutical Preparations · CIK 1590560
Develops single-treatment gene therapies with potentially curative results for devastating diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 4, 2026: 6 sold $2.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Kapusta Matthew CCEO, Managing Director | Sell | 14,581 | $9.06 | $132K |
| Mar 4, 2026 | Klemt ChristianChief Financial Officer | Sell | 12,000 | $9.06 | $109K |
| Mar 4, 2026 | Potts JeannetteChief Legal Officer | Sell | 3,412 | $9.06 | $31K |
| Mar 4, 2026 | Abi-Saab WalidChief Medical Officer | Sell | 808 | $9.06 | $7K |
| Mar 2, 2026 | Kapusta Matthew CCEO, Managing Director | Sell | 34,437 | $9.95 | $343K |
| Mar 2, 2026 | Klemt ChristianChief Financial Officer | Sell | 12,532 | $9.95 | $125K |
| Mar 2, 2026 | Potts JeannetteChief Legal Officer | Sell | 8,578 | $9.95 | $85K |
| Mar 2, 2026 | Abi-Saab WalidChief Medical Officer | Sell | 1,660 | $9.95 | $17K |
| Feb 25, 2026 | Kapusta Matthew CCEO, Managing Director | Sell | 12,378 | $23.86 | $295K |
| Feb 25, 2026 | Klemt ChristianChief Financial Officer | Sell | 6,217 | $23.86 | $148K |
| Jan 12, 2026 | Gut RobertDirector | Sell | 17,310 | $24.39 | $422K |
| Jan 12, 2026 | Gut RobertDirector | Sell | 7,803 | $25.09 | $196K |
| Jan 12, 2026 | Gut RobertDirector | Sell | 500 | $25.03 | $13K |
| Jan 9, 2026 | Kaye JackDirector | Sell | 6,390 | $27.28 | $174K |
| Nov 6, 2025 | Gut RobertDirector | Sell | 15,840 | $27.22 | $431K |
| Nov 6, 2025 | Gut RobertDirector | Sell | 15,594 | $27.30 | $426K |
| Nov 4, 2025 | Kaye JackDirector | Sell | 17,810 | $30.33 | $540K |
| Nov 4, 2025 | Kaye JackDirector | Sell | 11,000 | $30.34 | $334K |
| Nov 4, 2025 | Kaye JackDirector | Sell | 10,000 | $30.36 | $304K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Coverage (30d): 7 reputable articles.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗